Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Paraneoplastic Neuromyelitis Optica Spectrum Disorders: Three New Cases and A Review of the Literature.
Neurogenic pulmonary edema in pediatric multiple sclerosis: patient report and summary of cases.
Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
[Pelvic floor muscles training, electrical stimulation, bladder training and lifestyle interventions to manage lower urinary tract dysfunction in multiple sclerosis: A systematic review].
Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosis.
Propentofylline treatment on open field behavior in rats with focal ethidium bromide-induced demyelination in the ventral surface of the brainstem.
Myelin proteomics: the past, the unexpected and the future.
Fitness and cognitive processing speed in persons with multiple sclerosis: A cross-sectional investigation.
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Month of birth and risk of multiple sclerosis in Kuwait: A population-based registry study.
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis.
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
Cdon, a cell surface protein, mediates oligodendrocyte differentiation and myelination.
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
Orthognathic Surgery in a Patient with Multiple Sclerosis.
Testing different ICA algorithms and connectivity analyses on MS patients.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Early White Matter Changes in Childhood Multiple Sclerosis: A Diffusion Tensor Imaging Study.
Response to comment on "dimethyl fumarate (tecfidera): a new oral agent for multiple sclerosis".
Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
Pages
« first
‹ previous
…
405
406
407
408
409
410
411
412
413
…
next ›
last »